Embla Medical hf. Share Price
Stocks
EMBLA
IS0000000040
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.15 DKK | -0.37% |
|
+3.79% | -15.69% |
| Market Cap | 1.77B 11.62B 1.55B 1.44B 1.33B 2.5B 171B 2.53B 17.18B 6.72B 83.68B 6.66B 6.51B 289B | P/E 2026 * |
18x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.19B 14.34B 1.92B 1.78B 1.64B 3.08B 211B 3.12B 21.21B 8.3B 103B 8.21B 8.04B 357B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.93x |
| Free-Float |
36.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Embla Medical hf.
| 1 day | -0.37% | ||
| 1 week | +3.79% | ||
| Current month | +2.24% | ||
| 1 month | +4.98% | ||
| 3 months | -2.14% | ||
| 6 months | -14.38% | ||
| Current year | -15.69% |
| 1 week | 26.25 | 27.85 | |
| 1 month | 25.55 | 27.85 | |
| Current year | 25 | 33.1 | |
| 1 year | 25 | 37.9 | |
| 3 years | 25 | 38 | |
| 5 years | 25 | 49.45 | |
| 10 years | 22.5 | 57.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 48 | 31/03/2022 |
| Director of Finance/CFO | 60 | 31/08/2022 | |
Andr Rocha
CTO | Chief Tech/Sci/R&D Officer | - | 23/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 31/12/2008 | |
Niels Jacobsen
CHM | Chairman | 68 | 31/12/2005 |
Svafa Grönfeldt
BRD | Director/Board Member | 61 | 31/01/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/12/25 | Buy | Company | 10,400 | 0.0024% | ||
| 15/12/25 | Buy | Company | 45,275 | 0.0106% | ||
| 08/12/25 | Buy | Company | 30,000 | 0.0070% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +3.79% | -14.91% | -13.97% | 1.77B | ||
| -0.52% | -5.15% | -5.56% | -29.42% | 19.47B | ||
| +4.74% | +1.74% | -8.86% | -11.58% | 14.66B | ||
| -4.92% | -9.52% | -63.84% | -52.21% | 5.41B | ||
| -1.16% | +2.79% | - | - | 4.07B | ||
| +0.88% | +6.26% | +51.28% | +17.35% | 1.72B | ||
| -1.30% | -4.50% | -41.74% | -61.09% | 1.17B | ||
| +1.75% | -2.51% | +13.16% | +161.43% | 442M | ||
| +30.00% | +18.18% | - | - | 293M | ||
| +5.35% | -1.24% | -34.23% | - | 166M | ||
| Average | +3.45% | +2.34% | -13.09% | +1.50% | 4.92B | |
| Weighted average by Cap. | +0.78% | -1.36% | -12.72% | -22.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.02B 6.69B 894M 829M 763M 1.44B 98.26B 1.46B 9.89B 3.87B 48.16B 3.83B 3.75B 166B | 1.1B 7.22B 966M 895M 824M 1.55B 106B 1.57B 10.69B 4.18B 52.04B 4.14B 4.05B 180B |
| Net income | 100M 657M 87.87M 81.42M 74.94M 141M 9.65B 143M 972M 380M 4.73B 376M 368M 16.34B | 110M 721M 96.43M 89.35M 82.24M 155M 10.6B 157M 1.07B 417M 5.19B 413M 404M 17.93B |
| Net Debt | 416M 2.72B 364M 337M 311M 586M 40.02B 593M 4.03B 1.58B 19.61B 1.56B 1.53B 67.71B | 356M 2.33B 312M 289M 266M 501M 34.26B 508M 3.45B 1.35B 16.79B 1.34B 1.31B 57.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | DKK 27.20 | -0.18% | 3,285 |
| 21/07/26 | DKK 27.25 | +3.42% | 156,233 |
| 20/07/26 | DKK 26.35 | -0.57% | 161,751 |
| 17/07/26 | DKK 26.50 | 0.00% | 104,272 |
| 16/07/26 | DKK 26.50 | +0.38% | 69,901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMBLA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















